Loading clinical trials...
Loading clinical trials...
The most powerful protective mechanism against ischemia-reperfusion injury other than rapid reperfusion is ischemic preconditioning. Ischemic preconditioning is defined as the development of tolerance...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Radboud University Medical Center
NCT06097702 · Ischemia-reperfusion Injury
NCT03031470 · Ischemia-reperfusion Injury in Liver Transplant, Early Allograft Dysfunction
NCT00224406 · Ischemia-Reperfusion Injury, Lung Transplantation
NCT05327348 · Oxidative Stress, Ischemia-reperfusion Injury
NCT01739088 · Congenital Heart Disease, Ischemia-reperfusion Injury
Radboud University Nijmegen Medical Centre / Department of Pharmacology and Toxicology
Nijmegen, Gelderland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions